Remove Compounding Remove Pharmaceutical Companies Remove Presentation
article thumbnail

New European monograph for Cannabis flower adopted

European Pharmaceutical Review

.” Implementing quality standards for medicinal cannabis Mikael Sodergren of Curaleaf International explained in an article published on EPR’s website last month: “there is a vast range of flavonoids, terpenoids, phytols and other compounds present at lower concentrations within the cannabis flower”.

article thumbnail

The role of outsourcing in antibody drug manufacture

European Pharmaceutical Review

A study investigating the trend for existing pharmaceutical companies to outsource to contracted development and manufacturing organisations (CDMOs), analysing the position of companies manufacturing monoclonal antibody drugs (mAbs). Yoshiura et al. Yoshiura et al.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Utilising content metrics to improve digital engagement

pharmaphorum

Pharma companies are producing and distributing more digital content than ever due to the pandemic, meaning the content presented needs to stand out in the crowded digital space to garner attention. Content metrics is the collection of data related to an industry or a company’s content.

article thumbnail

Patient Engagement in Pharma – Why and How?

Viseven

In an era where medicine is rapidly becoming more personalized, why do pharmaceutical companies still struggle to effectively engage with the very individuals they aim to serve? Additionally, the COVID-19 pandemic has intensified public scrutiny of pharmaceutical companies, creating a unique opportunity to build trust with patients.

article thumbnail

ISPE Briefs: New Guide Explores Best Practices in Pharmaceutical Containment

ISPE

The ISPE Good Practice Guide: Containment for Potent Compounds covers all aspects of pharmaceutical containment, including background to safe working levels, mechanisms of exposure, and how exposure can be controlled.

article thumbnail

GLP1 Receptor Agonist Market: Current Landscape, Growth Opportunities and Future Market Outlook

Roots Analysis

GLP-1 receptor agonist market have captured the attention of both large and small pharmaceutical companies, for more than a decade. GLP-1 Receptor Agonist Market – Current Landscape Presently, more than 150 GLP-1 drug candidates have been commercialized / being developed by more 55 developers to treat various metabolic disorders.

article thumbnail

GSK continues campaign for greater adult immunisation coverage

pharmaphorum

As a result, the company recently conducted an online study, alongside Kantar, a data analytics and brand consulting company, to provide insights on what people are looking for in their vaccine decision-making process. Why adult immunisation is important. The role of HCPs.